Zobrazeno 1 - 10
of 80
pro vyhledávání: '"B P, Matveev"'
Publikováno v:
Onkourologiâ, Vol 3, Iss 2, Pp 5-11 (2020)
Objective: to assess the results of organ-preserving treatment of patients with renal cell carcinoma (RCC).Materials and methods: 238 patients with renal tumors underwent partial nephrectomy at our institution between 1971 and 2006. 35(14.7%) of 238
Autor:
O. B. Karyakin, B. P. Matveev, V. B. Matveev, I. G. Rusakov, O. B. Loran, Ye. I. Veliyev, L. V. Shaplygin, B. V. Bukharkin, V. A. Biryukov, N. G. Minayeva, A. A. Atayev, V. M. Shelepova, M. I. Karelin, D. G. Prokhorov, Yu. N. Khrizman, V. K. Shakurov, E. F. Abdrakhmanov, V. N. Zhuravlev, A. V. Zyryanov, V. O. Mager, P. A. Karnaukh
Publikováno v:
Onkourologiâ, Vol 3, Iss 2, Pp 56-60 (2020)
Introduction: Hormonal therapy is the method of choice in treating disseminated prostate cancer. Chronic androgenic suppression causes a reduction in bone mineral density. The most common complications of bone metastases are pathological fractures, s
Publikováno v:
Современная онкология, Vol 7, Iss 2, Pp 68-72 (2005)
Проблема метастазирования рака почки в кости в настоящее время хорошо освещена в научной печати, но изучена, пожалуй, недостаточно. На с
Externí odkaz:
https://doaj.org/article/d156237b86ae422ba1f047248d3d8309
Autor:
B P Matveev, B V Bukharkin
Publikováno v:
Современная онкология, Vol 5, Iss 3, Pp 114-119 (2003)
В лечении ГР-РПЖ намечаются определенные сдвиги. Так, на основании проведенных исследований можно предположить, что использование касо
Externí odkaz:
https://doaj.org/article/a46204d8ca5a41de9c4ba0de72bc0ec1
Autor:
B P Matveev, O B Karyakin, V B Matveev, Yu G Alyaev, I G Rusakov, A Z Vinarov, B V Bukharkin, L V Shaplygin, B Ya Alekseev, V A Biryukov, S V Galanin, V P Izgeym, A V Lykov, Yu N Khrizman, K Sh Gantsev, P A Karnaukh
Publikováno v:
Современная онкология, Vol 6, Iss 3, Pp 111-113 (2004)
Рак предстательной железы (РПЖ) - одно из наиболее распространенных заболеваний у мужчин пожилого возраста. При наличии костных метаста
Externí odkaz:
https://doaj.org/article/36beef7336064c80815d888dc1b3898c
Publikováno v:
Urologiia (Moscow, Russia : 1999). (6)
Cystectomy in the treatment of invasive cancer of the urinary bladder is not the only therapeutic modality in this pathology. In selected patients an alternative exists--transurethral resection of the urinary bladder followed by adjuvant concurrent c
Publikováno v:
Urologiia (Moscow, Russia : 1999). (4)
A total of 59 patients with hormone-resistent prostatic cancer (HDPC) treated in 1999-2004 entered the trial. Three schemes of first-line chemotherapy were examined for clinical efficacy and toxicity in the above patients. Anticancer combined treatme
Publikováno v:
Urologiia (Moscow, Russia : 1999). (4)
Emergence of regional penile cancer (PC) metastases reduces late survival of PC patients from 94.4 to 83.9%. PC stage can hardly be diagnosed by clinical data significantly. Bilateral inguinal lymphadenectomy is indicated for all PC patients with enl
Autor:
B P, Matveev, B V, Bukharkin
Publikováno v:
Urologiia (Moscow, Russia : 1999). (6)
As the literature data give arguments both pro and contra wide use of maximal androgenic block (MAB) in the treatment of prostatic cancer, the authors studied MAB in 200 patients. They came to the conclusion that MAB can be applied in patients with s
Autor:
E M, Aksel', B P, Matveev
Publikováno v:
Urologiia i nefrologiia. (2)
The trends in male urinary and genital cancer morbidity and mortality are specified. Statistics on separate malignant urological diseases are provided. In 1996 the number of patients with cancer of male urinary and sex organs reached 31.700. A growth